JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
80 hedge funds and large institutions have $122M invested in Jounce Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% less capital invested
Capital invested by funds: $153M → $122M (-$31.8M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
80
Holding in Top 10
2
Calls
$161K
Puts
$58K
Top Buyers
| 1 | +$933K | |
| 2 | +$693K | |
| 3 | +$650K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$595K |
| 5 |
SO
STRS Ohio
Columbus,
Ohio
|
+$470K |
Top Sellers
| 1 | -$1.14M | |
| 2 | -$496K | |
| 3 | -$489K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$432K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$371K |